S
HZNP

SignatureFD’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

SignatureFD’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,497
Closed -$289K – 3338
2023
Q3 		$289K Sell
2,497
-7
-0.3% -$752 0.01% 611
2023
Q2 		$258K Sell
2,504
-25
-1% -$2.64K 0.01% 658
2023
Q1 		$276K Sell
2,529
-64
-2% -$7.07K 0.01% 617
2022
Q4 		$295K Buy
2,593
+224
+9% +$18.6K 0.01% 566
2022
Q3 		$147K Buy
2,369
+440
+23% +$30.7K 0.01% 787
2022
Q2 		$154K Sell
1,929
-2,089
-52% -$198K 0.01% 795
2022
Q1 		$423K Buy
4,018
+2,685
+201% +$262K 0.01% 459
2021
Q4 		$144K Buy
1,333
+33
+3% +$3.6K ﹤0.01% 861
2021
Q3 		$142K Buy
1,300
+153
+13% +$15.9K ﹤0.01% 830
2021
Q2 		$107K Buy
1,147
+96
+9% +$8.83K ﹤0.01% 928
2021
Q1 		$97K Buy
1,051
+154
+17% +$13K ﹤0.01% 894
2020
Q4 		$66K Buy
897
+1
+0.1% +$74 ﹤0.01% 960
2020
Q3 		$70K Buy
896
+344
+62% +$23.7K ﹤0.01% 844
2020
Q2 		$31K Buy
552
+133
+32% +$5.69K ﹤0.01% 1150
2020
Q1 		$12K Buy
419
+373
+811% +$12.6K ﹤0.01% 1425
2019
Q4 		$2K Hold
46
– – ﹤0.01% 1972
2019
Q3 		$1K Hold
46
– – ﹤0.01% 2077
2019
Q2 		$1K Hold
46
– – ﹤0.01% 2010
2019
Q1 		$1K Hold
46
– – ﹤0.01% 1947
2018
Q4 		$1K Hold
46
– – ﹤0.01% 1913
2018
Q3 		$1K Sell
46
-650
-93% -$12.4K ﹤0.01% 1887
2018
Q2 		$12K Buy
696
+650
+1,413% +$9.91K ﹤0.01% 1354
2018
Q1 		$1K Buy
+46
New +$680 ﹤0.01% 1720

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SignatureFD's HZNP Position: Q4 2023 in Review

SignatureFD sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,497 shares — an estimated $289K sold.

SignatureFD first reported a position in HZNP in Q1 2018 and held it in 23 quarters. The position peaked at $423K in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • SignatureFD reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • SignatureFD sold 2,497 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $289K.
  • SignatureFD first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2018 and held it in 23 quarters.
  • SignatureFD's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $423K in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on SignatureFD's 13F filing for Q4 2023, filed 1 Feb 2024.